Both in Pharmaceuticals
Trevi Therapeutics vs Agios Pharmaceuticals
Over the past year TRVI returned +18.8% and AGIO returned −10.9%; their daily moves had a correlation of 0.20.
TRVI +18.8% AGIO −10.9%Growth of $1, one year, split-adjusted
| Metric | TRVI | AGIO |
|---|---|---|
| Price | $12.94 | $37.19 |
| Market cap | $1.84B | $2.22B |
| Today | +1.33% | +0.03% |
| 1 month | −10.5% | +8.8% |
| 6 months | −8.8% | +44.5% |
| Year to date | +3.4% | +36.6% |
| 1 year | +21.5% | −14.4% |
| Revenue growth (YoY) | — | +259.3% |
| Gross margin | — | 93.3% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 22.6× |
| Net cash | $318.9M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | 37.9% | 46.3% |
| Short % of float | 13.1% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).